Moreover, the transcription of E2F4 (Figure 5B) mRNA was downregulated in UCEC patients compared with healthy individuals in subgroup analyses based on race, weight, age, menopause status, histological subtypes, TP53 mutation status, and cancer stage. This evidence concerns the gene E2F4 and cancer.